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Background: Ovarian cancer is currently the most lethal gynecologic malignancy. Despite the poor prognosis, most
ovarian cancers are detected at Stages III and IV due to the lack of early diagnostic methods and ambiguous
disease presentation. In recent years, repetitive elements (REs) have emerged as a potential early diagnostic
marker for ovarian cancers. While expression of REs is largely silenced in normal cells via methylation, they are
often transcribed in cancer, likely due to broad hypomethylation of cancer genomes. Although broad
overexpression of REs has been observed in ovarian cancer, specific REs that are consistently upregulated in cancer
progression have not been identified, nor have their impacts on disease progression been evaluated. In addition,
there has not been sufficient research analyzing differential RE expression and methylation in tandem to discern if
hypomethylation truly causes RE expression during cancer initiation. The aim of this study was to identify
significantly upregulated or downregulated REs and their associated methylation profiles in both immortalized
fallopian tube secretory epithelial cells (FTSEC) and a cancer progression model.
Results and Conclusions: The cancer progression model showed differential expression compared to controls.
Most elements were overexpressed as predicted, though there were a significant number of repetitive elements
demonstrating reduced expression. The methylation analysis showed evidence of broad hypomethylation. Unlike
hypothesized however, the immortalized FTSECs had near ubiquitous downregulation of repetitive elements.

Figure 4. Class composition of differentially expressed elements. Differential expression was determined by
comparing each step of progression to the to early passage (EP) stage. Long Terminal Repeats (LTR) are the most
commonly over- (Figure 4A) and underexpressed (Figure 4B) RE. This is significant because LTR elements can
function as both enhancers and promoters, so their errant expression could impact the transcription of proteincoding genes or other REs. The introduction of the HRAS mutation also saw an increase in expression of long
interspersed elements (LINEs). Long interspersed element-1 comprises 17% of the human genome and some have
retained autonomous retrotransposition capabilities. These elements are potentially responsible for large deletion
events that remove tumor suppressor genes. Figure by Tomas Kanholm.
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Figure 1. Stepwise transduction of BJ fibroblasts to generate cancer progression model done by Easwaran Lab
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A. BJ fibroblast cells underwent serial transduction with driver mutations hTERT, SV40 large T antigen, and HRAS to
create a cancer progression model
B. RNA-Seq data and whole genome bisulfite sequencing data was collected from the cells at each stage of
progression.
C. RNA-Seq data underwent underwent quality controls using the softwares FastQC and Cutadapt. The cleaned data
was then aligned to the reference genome hg38 using the software STAR.
D. Read calling of repetitive elements (REs) was done concurrently on two platforms, TEtranscripts and Telescope,
after which differential expression analysis was done on resultant count tables using DESeq2.
E. Methylation analysis was conducted on methylKit using whole genome bisulfite sequencing data.
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Figure 7. Prinical Component Analysis (PCA) of immortalized FTSECs and normal fallopian tube epithelium (NFTE).
Principal component analysis of the data reveals the formation of two independent clusters within the normal
fallopian tube epithelium (NFTE) cells in both the TEtranscripts (Figure 7A) and Telescope (Figure 7B) results.
However, the immortalized cells aggregate close together in both plots. Analysis was done following the removal of
potential in silico rRNA contamination.
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Figure 5. Summary results of Telescope analysis. Telescope, created by the Crandall Lab at the GW Computational
Biology Institute, is distinct from TEtranscripts for its ability to provides locus-specific quantification of select REs.
While the plots indicate increased dysregulation of expression as mutations are introduced as expected, far more
elements are downregulated compared to the TEtranscripts results. This could be due to the fact that Telescope
examines a more limited range of REs than TEtranscripts. Figure by Tomas Kanholm.
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Figure 2. Stepwise alterations to create immortalized FTSEC cells done by Drapkin Lab. Figure 2A depicts the steps
to create cell line FT33-TAG; Figure 2B depicts the steps to create cell lines FT189, FT190, and FT194; Figure 2C
depicts the steps to create cell lines FT237, FT240 and FT246; and Figure 2D depicts the steps to create cell line
FT282. The multiple cell lines can better model ovarian cancers with different mutational profiles.
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Figure 8. Summary results of TEtranscripts and Telescope analysis. Unlike the transformed BJ Fibroblast lines, the
immortalized FTSECs show widespread downregulation of repetitive elements compared to NFTE in both
TEtranscripts (Figure 8A) and Telescope (Figure 8C). The Telescope results show that while many LINE and LTR
elements show statistically significant differential expression, they are largely underexpressed compared to NFTE cells
(Figure 8D). Figure by Tomas Kanholm.
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Figure 3. Summary results of TEtranscripts analysis. The software TEtrancripts is notable for its ability map short
sequencing reads to repetitive regions of the genome. It can also handle multi-reads, or short reads that may map to
multiple sites of the reference genome. These elements are often attributed to transposable elements. While many
analysis tools ignore them or have poor accuracy given the high-level ambiguity, TEtrancripts can handle repetitive
elements well in addition to conventional genes, making it a good candidate to assist with differential expression
analysis. As hypothesized, the overexpression of REs increased at each step of the transformation process (Figure 3A).
The volcano plot (Figure 3B) indicates that most of the differentially expressed elements had a P-value of < 0.05.
Figure by Tomas Kanolm.
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F. After preliminary results were found using the cancer progression model, RNA-Seq data was collected from
immortalized fallopian tube secretory epithelial cells (FTSEC). RNA-Seq data was also collected from the fallopian
tissue of control patients.
G. RNA-Seq data underwent the same quality control as the immortalized BJ fibroblast cell line, followed by removal
of potential rRNA contamination with SortMeRNA.
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Figure 6. Summary results of methylKit methylation analysis. These results indicate that there was some level of
hypermethylation (Figure 6A), but the overall difference is much smaller than hypomethylation. As predicted, the
percentage of hypomethylated features increased as the BJ fibroblast cells were immortalized (Figure 6B). Despite
HRAS1 and HRAS3 being replicates, the two tests showed large differences in results. For example, 8.22% of HRAS3
features were hypomethylated while only 2.6% of HRAS1 features were. At the final stage of the immortalization
process—the introduction of HRAS—0.66% of promoters and 0.05% of exons overlapped with differentially
methylated regions (Figure 6D). Most DMRs overlapped with introns and intergenic regions, which is to be expected
given that they occupy a large portion of the entire genome.

A. The cancer progression model showed both overexpression and hypomethylation, results supported by
previous studies. Moving forward, repetitive elements that are substantially and significantly differentially
expressed will be mutated in ovarian cancer models to determine phenotypic changes.
B. While methylKit provides good summary statistics, other softwares provide specific genomic coordinates to
differentially methylated regions (DMRs). Future directions include using DSS and WIMSi to isolate DMRs for
further study.
C. Immortalized fallopian tube secretory epithelial cells (FTSEC) were found to induce decreased expression of
elements compared to controls. This result was unexpected given previous findings. Future work includes
determining the reasons behind this change and the cause of the clustering seen on the PCA plots.
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